Baxter International Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Baxter International Inc. on October 3, 2006. The report details corporate governance changes approved by the Board of Directors on the same date, specifically regarding director compensation and voting procedures.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance and compensation amendments rather than financial performance.
Material Changes
- Director Compensation: Effective January 1, 2007, the annual retainer for non-employee directors will increase from $45,000 to $50,000. Meeting fees will rise from $1,000 to $1,500 per Board or committee meeting attended. The fee for chairing a committee meeting will also increase from $1,000 to $1,500.
- Equity Awards: Effective May 2007, directors will receive annual awards of restricted stock units (RSUs) instead of restricted stock. Directors will have the option to defer receipt of underlying shares until the earlier of three years from the grant date or termination of service.
- Voting Standards: The Company amended its Bylaws to implement majority voting for the election of directors in uncontested elections, replacing the previous plurality vote standard. This change applies beginning with the next election of directors.
Outlook, Risks, and Management Commentary
Management commentary is limited to the description of the approved amendments. No specific financial guidance, outlook, risks, or contingencies are disclosed in this filing. The changes are intended to align director compensation with market standards and enhance shareholder voting rights.
Key Facts for Investor Verification
- Verify the effective dates for the compensation increases (January 1, 2007) and the shift to RSUs (May 2007).
- Confirm the implementation timeline for the new majority voting standard in the next director election.
- Review the attached amended plans (Exhibits 10.1 and 10.2) for specific terms regarding deferral options and vesting schedules.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.